360 related articles for article (PubMed ID: 34345021)
21. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.
Mankia K; Siddle HJ; Kerschbaumer A; Alpizar Rodriguez D; Catrina AI; Cañete JD; Cope AP; Daien CI; Deane KD; El Gabalawy H; Finckh A; Holers VM; Koloumas M; Ometto F; Raza K; Zabalan C; van der Helm-van Mil A; van Schaardenburg D; Aletaha D; Emery P
Ann Rheum Dis; 2021 Oct; 80(10):1286-1298. PubMed ID: 34362746
[TBL] [Abstract][Full Text] [Related]
22. The susceptibility of attaining and maintaining DMARD-free remission in different (rheumatoid) arthritis phenotypes.
Luurssen-Masurel N; van Mulligen E; Weel-Koenders AEAM; Hazes JMW; de Jong PHP;
Rheumatology (Oxford); 2021 Aug; ():. PubMed ID: 34352094
[TBL] [Abstract][Full Text] [Related]
23. Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Maksymowych WP; Østergaard M; Landewé R; Barchuk W; Liu K; Tasset C; Gilles L; Hendrikx T; Besuyen R; Baraliakos X
Rheumatology (Oxford); 2022 May; 61(5):2063-2071. PubMed ID: 34352069
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Izmirly PM; Kim MY; Samanovic M; Fernandez-Ruiz R; Ohana S; Deonaraine KK; Engel AJ; Masson M; Xie X; Cornelius AR; Herati RS; Haberman RH; Scher JU; Guttmann A; Blank RB; Plotz B; Haj-Ali M; Banbury B; Stream S; Hasan G; Ho G; Rackoff P; Blazer AD; Tseng CE; Belmont HM; Saxena A; Mulligan MJ; Clancy RM; Buyon JP
Arthritis Rheumatol; 2022 Feb; 74(2):284-294. PubMed ID: 34347939
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
Blauvelt A; Teixeira HD; Simpson EL; Costanzo A; De Bruin-Weller M; Barbarot S; Prajapati VH; Lio P; Hu X; Wu T; Liu J; Ladizinski B; Chu AD; Eyerich K
JAMA Dermatol; 2021 Sep; 157(9):1047-1055. PubMed ID: 34347860
[TBL] [Abstract][Full Text] [Related]
26. Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease course.
Heckert SL; Bergstra SA; Matthijssen XME; Goekoop-Ruiterman YPM; Fodili F; Ten Wolde S; Allaart CF; Huizinga TWJ
Ann Rheum Dis; 2022 Feb; 81(2):169-174. PubMed ID: 34462262
[TBL] [Abstract][Full Text] [Related]
27. Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus.
Stefanski AL; Dörner T
Curr Opin Rheumatol; 2021 Nov; 33(6):592-597. PubMed ID: 34402453
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3.
Aletaha D; Westhovens R; Gaujoux-Viala C; Adami G; Matsumoto A; Bird P; Messina OD; Buch MH; Bartok B; Yin Z; Guo Y; Hendrikx T; Burmester GR
RMD Open; 2021 Aug; 7(2):. PubMed ID: 34385364
[TBL] [Abstract][Full Text] [Related]
29. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE.
Caielli S; Cardenas J; de Jesus AA; Baisch J; Walters L; Blanck JP; Balasubramanian P; Stagnar C; Ohouo M; Hong S; Nassi L; Stewart K; Fuller J; Gu J; Banchereau JF; Wright T; Goldbach-Mansky R; Pascual V
Cell; 2021 Aug; 184(17):4464-4479.e19. PubMed ID: 34384544
[TBL] [Abstract][Full Text] [Related]
30. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
Jung SM; Park KS; Kim KJ
Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701
[TBL] [Abstract][Full Text] [Related]
31. Preclinical models of arthritis for studying immunotherapy and immune tolerance.
Meehan GR; Thomas R; Al Khabouri S; Wehr P; Hilkens CM; Wraith DC; Sieghart D; Bonelli M; Nagy G; Garside P; Tough DF; Lewis HD; Brewer JM
Ann Rheum Dis; 2021 Oct; 80(10):1268-1277. PubMed ID: 34380700
[TBL] [Abstract][Full Text] [Related]
32. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
[TBL] [Abstract][Full Text] [Related]
33. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.
Taft J; Markson M; Legarda D; Patel R; Chan M; Malle L; Richardson A; Gruber C; Martín-Fernández M; Mancini GMS; van Laar JAM; van Pelt P; Buta S; Wokke BHA; Sabli IKD; Sancho-Shimizu V; Chavan PP; Schnappauf O; Khubchandani R; Cüceoğlu MK; Özen S; Kastner DL; Ting AT; Aksentijevich I; Hollink IHIM; Bogunovic D
Cell; 2021 Aug; 184(17):4447-4463.e20. PubMed ID: 34363755
[TBL] [Abstract][Full Text] [Related]
34. Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study.
Kong X; Sun Y; Dai X; Wang L; Ji Z; Chen H; Jin X; Ma L; Jiang L
Ann Rheum Dis; 2022 Jan; 81(1):117-123. PubMed ID: 34362744
[TBL] [Abstract][Full Text] [Related]
35. CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
Mougiakakos D; Krönke G; Völkl S; Kretschmann S; Aigner M; Kharboutli S; Böltz S; Manger B; Mackensen A; Schett G
N Engl J Med; 2021 Aug; 385(6):567-569. PubMed ID: 34347960
[No Abstract] [Full Text] [Related]
36. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
[TBL] [Abstract][Full Text] [Related]
37. Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy.
Dorst DN; Rijpkema M; Buitinga M; Walgreen B; Helsen MMA; Brennan E; Klein C; Laverman P; Ramming A; Schmidkonz C; Kuwert T; Schett G; van der Kraan PM; Gotthardt M; Koenders MI
Rheumatology (Oxford); 2022 Jul; 61(7):2999-3009. PubMed ID: 34450633
[TBL] [Abstract][Full Text] [Related]
38. The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions.
Fragoulis GE; Brock J; Basu N; McInnes IB; Siebert S
J Allergy Clin Immunol; 2021 Oct; 148(4):941-952. PubMed ID: 34450118
[TBL] [Abstract][Full Text] [Related]
39. Role of diagnostic imaging in psoriatic arthritis: how, when, and why.
Crespo-Rodríguez AM; Sanz Sanz J; Freites D; Rosales Z; Abasolo L; Arrazola J
Insights Imaging; 2021 Aug; 12(1):121. PubMed ID: 34432145
[TBL] [Abstract][Full Text] [Related]
40. Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy.
Takeuchi T; Fleischmann R; Iikuni N; Shi H; Soma K; Paulissen J; Hirose T; Smolen JS
Arthritis Res Ther; 2021 Aug; 23(1):220. PubMed ID: 34429160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
